High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis (Q33765551)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

Marco Matucci-Cerinic

6

object named as

Marco Matucci-Cerinic

0 references

Otylia Kowal-Bielecka

1

object named as

Otylia Kowal-Bielecka

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Serena Guiducci

3

object named as

Serena Guiducci

0 references

7

object named as

Marek Brzosko

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dorota Krasowska

8

object named as

Dorota Krasowska

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lech Chyczewski

9

object named as

Lech Chyczewski

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

object named as

Marek Bielecki

2

0 references

Małgorzata Michalska-Jakubus

5

object named as

Małgorzata Michalska-Jakubus

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Serena Guiducci

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Beata Trzcinska-Butkiewicz

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Krzysztof Kowal

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Arthritis Research and Therapy

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

R69

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

New insights into the role of oxidative stress in scleroderma fibrosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

CD163 and its role in inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Innate immunity and inflammation in systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Overview of pathogenesis of systemic sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Expression and function of fibroblast growth factor-inducible 14 in human corneal myofibroblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-ph

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

No end in site: TWEAK/Fn14 activation and autoimmunity associated- end-organ pathologies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Criteria for the classification of early systemic sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Identification of the haemoglobin scavenger receptor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Phenotypic dynamics of macrophage subpopulations during human experimental gingivitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

22 June 2018

Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163.

1 reference

https://api.crossref.org/works/10.1186%2FAR4246

21 January 2018

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1186%2FAR4246

21 January 2018

Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial

1 reference

https://api.crossref.org/works/10.1186%2FAR4246

21 January 2018

EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research

1 reference

https://api.crossref.org/works/10.1186%2FAR4246

21 January 2018

Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: detoxifying mechanisms and potential therapeutic options.

1 reference

https://api.crossref.org/works/10.1186%2FAR4246

21 January 2018

Heterogeneity of macrophage populations and expression of galectin-3 in cutaneous wound healing in rats.

1 reference

https://api.crossref.org/works/10.1186%2FAR4246

21 January 2018

Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

30 October 2018

Support of HUVEC proliferation by pro-angiogenic intermediate CD163+ monocytes/macrophages: a co-culture experiment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

30 October 2018

Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

30 October 2018

Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4060194

30 October 2018

Increased serum levels of soluble CD163 in patients with scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23800379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diminished production of TWEAK by the peripheral blood mononuclear cells is associated with vascular involvement in patients with systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23800379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23800379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23800379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23800379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of soluble CD163 in patients with systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23800379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23800379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of monocyte CD163 in single ? and dual-asthmatic responders during allergen-induced bronchoconstriction

1 reference

https://pubmed.ncbi.nlm.nih.gov/23800379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/23800379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33765551&oldid=2195758587"